Bilirubin index

A new standard for intervention?

P. A. Gustafson, David Boyle

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The current practice for treating neonates for jaundice centers on the recommendation that bilirubin levels should be kept below 20 mg/dL. Preventing bilirubin levels from exceeding 20 mg/dL, however, does not guarantee the avoidance of kernicterus, lower IQs or neurologic abnormalities. Studies in the 1960s and 1970s reported cases of infants with clinical and pathological kernicterus whose neonatal bilirubin levels were well below 20 mg/dL. It is now well accepted that protein binding, acidosis, hypoxia, intracranial hemorrhage and hemolytic disease play a role in facilitating bilirubin toxicity. This paper reviews previously published studies that were instrumental in identifying the role of hypoxia, acidosis, hemolytic disease, intracranial hemorrhage and protein binding in bilirubin encephalopathy and identifies two key variables which contribute to bilirubin flux - free bilirubin concentration and time. The paper proposes a new approach for evaluating bilirubin levels termed 'bilirubin index'. Future research should initially focus on healthy term infants without concomitant illness and should record free bilirubin levels as a function of time. The area under the bilirubin versus time curve represents the integration of bilirubin level with respect to time, or simply termed the 'bilirubin index'. The bilirubin index could then be correlated with parameters for measuring neurological outcome. Assuming a correlation would exist, the bilirubin index may then become the number for guidance with respect to intervention therapy. Attempting to address this issue by starting with a healthy population of neonates and correlating bilirubin index with neurological outcome offers a better chance for uncovering that 'threshold of toxicity'.

Original languageEnglish
Pages (from-to)409-416
Number of pages8
JournalMedical Hypotheses
Volume45
Issue number5
DOIs
StatePublished - 1995

Fingerprint

Bilirubin
Kernicterus
Intracranial Hemorrhages
Acidosis
Protein Binding
Newborn Infant
Nervous System Malformations
Jaundice

ASJC Scopus subject areas

  • Medicine(all)
  • Developmental Biology
  • Drug Discovery

Cite this

Bilirubin index : A new standard for intervention? / Gustafson, P. A.; Boyle, David.

In: Medical Hypotheses, Vol. 45, No. 5, 1995, p. 409-416.

Research output: Contribution to journalArticle

Gustafson, P. A. ; Boyle, David. / Bilirubin index : A new standard for intervention?. In: Medical Hypotheses. 1995 ; Vol. 45, No. 5. pp. 409-416.
@article{1a4ebada3b9c43fc8351c9b70aa1abb9,
title = "Bilirubin index: A new standard for intervention?",
abstract = "The current practice for treating neonates for jaundice centers on the recommendation that bilirubin levels should be kept below 20 mg/dL. Preventing bilirubin levels from exceeding 20 mg/dL, however, does not guarantee the avoidance of kernicterus, lower IQs or neurologic abnormalities. Studies in the 1960s and 1970s reported cases of infants with clinical and pathological kernicterus whose neonatal bilirubin levels were well below 20 mg/dL. It is now well accepted that protein binding, acidosis, hypoxia, intracranial hemorrhage and hemolytic disease play a role in facilitating bilirubin toxicity. This paper reviews previously published studies that were instrumental in identifying the role of hypoxia, acidosis, hemolytic disease, intracranial hemorrhage and protein binding in bilirubin encephalopathy and identifies two key variables which contribute to bilirubin flux - free bilirubin concentration and time. The paper proposes a new approach for evaluating bilirubin levels termed 'bilirubin index'. Future research should initially focus on healthy term infants without concomitant illness and should record free bilirubin levels as a function of time. The area under the bilirubin versus time curve represents the integration of bilirubin level with respect to time, or simply termed the 'bilirubin index'. The bilirubin index could then be correlated with parameters for measuring neurological outcome. Assuming a correlation would exist, the bilirubin index may then become the number for guidance with respect to intervention therapy. Attempting to address this issue by starting with a healthy population of neonates and correlating bilirubin index with neurological outcome offers a better chance for uncovering that 'threshold of toxicity'.",
author = "Gustafson, {P. A.} and David Boyle",
year = "1995",
doi = "10.1016/0306-9877(95)90213-9",
language = "English",
volume = "45",
pages = "409--416",
journal = "Medical Hypotheses",
issn = "0306-9877",
publisher = "Churchill Livingstone",
number = "5",

}

TY - JOUR

T1 - Bilirubin index

T2 - A new standard for intervention?

AU - Gustafson, P. A.

AU - Boyle, David

PY - 1995

Y1 - 1995

N2 - The current practice for treating neonates for jaundice centers on the recommendation that bilirubin levels should be kept below 20 mg/dL. Preventing bilirubin levels from exceeding 20 mg/dL, however, does not guarantee the avoidance of kernicterus, lower IQs or neurologic abnormalities. Studies in the 1960s and 1970s reported cases of infants with clinical and pathological kernicterus whose neonatal bilirubin levels were well below 20 mg/dL. It is now well accepted that protein binding, acidosis, hypoxia, intracranial hemorrhage and hemolytic disease play a role in facilitating bilirubin toxicity. This paper reviews previously published studies that were instrumental in identifying the role of hypoxia, acidosis, hemolytic disease, intracranial hemorrhage and protein binding in bilirubin encephalopathy and identifies two key variables which contribute to bilirubin flux - free bilirubin concentration and time. The paper proposes a new approach for evaluating bilirubin levels termed 'bilirubin index'. Future research should initially focus on healthy term infants without concomitant illness and should record free bilirubin levels as a function of time. The area under the bilirubin versus time curve represents the integration of bilirubin level with respect to time, or simply termed the 'bilirubin index'. The bilirubin index could then be correlated with parameters for measuring neurological outcome. Assuming a correlation would exist, the bilirubin index may then become the number for guidance with respect to intervention therapy. Attempting to address this issue by starting with a healthy population of neonates and correlating bilirubin index with neurological outcome offers a better chance for uncovering that 'threshold of toxicity'.

AB - The current practice for treating neonates for jaundice centers on the recommendation that bilirubin levels should be kept below 20 mg/dL. Preventing bilirubin levels from exceeding 20 mg/dL, however, does not guarantee the avoidance of kernicterus, lower IQs or neurologic abnormalities. Studies in the 1960s and 1970s reported cases of infants with clinical and pathological kernicterus whose neonatal bilirubin levels were well below 20 mg/dL. It is now well accepted that protein binding, acidosis, hypoxia, intracranial hemorrhage and hemolytic disease play a role in facilitating bilirubin toxicity. This paper reviews previously published studies that were instrumental in identifying the role of hypoxia, acidosis, hemolytic disease, intracranial hemorrhage and protein binding in bilirubin encephalopathy and identifies two key variables which contribute to bilirubin flux - free bilirubin concentration and time. The paper proposes a new approach for evaluating bilirubin levels termed 'bilirubin index'. Future research should initially focus on healthy term infants without concomitant illness and should record free bilirubin levels as a function of time. The area under the bilirubin versus time curve represents the integration of bilirubin level with respect to time, or simply termed the 'bilirubin index'. The bilirubin index could then be correlated with parameters for measuring neurological outcome. Assuming a correlation would exist, the bilirubin index may then become the number for guidance with respect to intervention therapy. Attempting to address this issue by starting with a healthy population of neonates and correlating bilirubin index with neurological outcome offers a better chance for uncovering that 'threshold of toxicity'.

UR - http://www.scopus.com/inward/record.url?scp=0028803779&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028803779&partnerID=8YFLogxK

U2 - 10.1016/0306-9877(95)90213-9

DO - 10.1016/0306-9877(95)90213-9

M3 - Article

VL - 45

SP - 409

EP - 416

JO - Medical Hypotheses

JF - Medical Hypotheses

SN - 0306-9877

IS - 5

ER -